User profiles for Alexandre Gaymard
 | Alexandre GaymardVerified email at chu-lyon.fr Cited by 5807 |
[PDF][PDF] Type I IFN immunoprofiling in COVID-19 patients
Funding-Quanterix provided the kits for this study free of charge. 37 Conflict of interest–Pons
S, Oriol G, Brengel-Pesce K, Mouton W, Compagnon C are Biomérieux® 38 employeers. …
S, Oriol G, Brengel-Pesce K, Mouton W, Compagnon C are Biomérieux® 38 employeers. …
[HTML][HTML] Clinical and virological data of the first cases of COVID-19 in Europe: a case series
…, M Parisey, PH Wicky, S Behillil, A Gaymard… - The Lancet Infectious …, 2020 - thelancet.com
Background On Dec 31, 2019, China reported a cluster of cases of pneumonia in people at
Wuhan, Hubei Province. The responsible pathogen is a novel coronavirus, named severe …
Wuhan, Hubei Province. The responsible pathogen is a novel coronavirus, named severe …
[HTML][HTML] First cases of coronavirus disease 2019 (COVID-19) in the WHO European Region, 24 January to 21 February 2020
…, M Diercke, C Campese, V Enouf, A Gaymard… - …, 2020 - eurosurveillance.org
In the WHO European Region, COVID-19 surveillance was implemented 27 January 2020.
We detail the first European cases. As at 21 February, nine European countries reported 47 …
We detail the first European cases. As at 21 February, nine European countries reported 47 …
[HTML][HTML] Two-step strategy for the identification of SARS-CoV-2 variant of concern 202012/01 and other variants with spike deletion H69–V70, France, August to …
We report the strategy leading to the first detection of variant of concern 202012/01 (VOC) in
France (21 December 2020). First, the spike (S) deletion H69–V70 (ΔH69/ΔV70), identified …
France (21 December 2020). First, the spike (S) deletion H69–V70 (ΔH69/ΔV70), identified …
Cluster of coronavirus disease 2019 (COVID-19) in the French Alps, February 2020
…, O Epaulard, T Bénet, A Gaymard… - Clinical Infectious …, 2020 - academic.oup.com
Background On 7 February 2020, French Health authorities were informed of a confirmed
case of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in an Englishman …
case of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in an Englishman …
Modeling SARS-CoV-2 viral kinetics and association with mortality in hospitalized patients from the French COVID cohort
…, I Engelmann, Q Lepiller, A Gaymard… - Proceedings of the …, 2021 - National Acad Sciences
The characterization of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral
kinetics in hospitalized patients and its association with mortality is unknown. We analyzed …
kinetics in hospitalized patients and its association with mortality is unknown. We analyzed …
[PDF][PDF] Characterization and treatment of SARS-CoV-2 in nasal and bronchial human airway epithelia
…, E Errazuriz-Cerda, J Fouret, J Dubois, A Gaymard… - Cell Reports …, 2020 - cell.com
In the current COVID-19 pandemic context, proposing and validating effective treatments
represents a major challenge. However, the scarcity of biologically relevant pre-clinical models …
represents a major challenge. However, the scarcity of biologically relevant pre-clinical models …
[HTML][HTML] Impact of original, B. 1.1. 7, and B. 1.351/P. 1 SARS-CoV-2 lineages on vaccine effectiveness of two doses of COVID-19 mRNA vaccines: Results from a …
…, A Septfons, S Cauchemez, A Gaymard… - The Lancet Regional …, 2021 - thelancet.com
Background We aimed to assess the effectiveness of two doses of mRNA COVID-19 vaccines
against COVID-19 with the original virus and other lineages circulating in France. Methods …
against COVID-19 with the original virus and other lineages circulating in France. Methods …
[HTML][HTML] Early assessment of diffusion and possible expansion of SARS-CoV-2 Lineage 20I/501Y. V1 (B. 1.1. 7, variant of concern 202012/01) in France, January to …
The emergence of SARS-CoV-2 variant 20I/501Y.V1 (VOC-202012/1 or GR/501Y.V1) is
concerning given its increased transmissibility. We reanalysed 11,916 PCR-positive tests (41% …
concerning given its increased transmissibility. We reanalysed 11,916 PCR-positive tests (41% …
[HTML][HTML] Performance assessment of SARS-CoV-2 PCR assays developed by WHO referral laboratories
…, L Josset, E Frobert, F Morfin, A Gaymard - Journal of clinical …, 2020 - mdpi.com
A reliable diagnostic assay is crucial to early detect new COVID-19 cases and limit severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission. Since the onset of the …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission. Since the onset of the …